The Microfluidics Prototype market is expected to grow from an estimated USD 715.5 million in 2024 to USD 4128.5 million in 2033, at a CAGR of 21.50%. The increased prevalence of chronic diseases like as diabetes, cardiovascular ailments, and cancer is a primary driving force behind the Global Microfluidics Prototype Market. These illnesses have reached pandemic proportions worldwide, demanding...